Company news
Hangzhou Tigermed Consulting Co., Ltd. Class A (SZSE:300347) news
Hangzhou Tigermed Consulting Co., Ltd. Class A news releases on 6ix. Latest, Sep 4, 2026: Hangzhou Tigermed Consulting : Tigermed and Veeda Lifesciences Forge…
Press releases & updates
Hangzhou Tigermed Consulting : Tigermed and Veeda Lifesciences Forge Strategic Clinical Research for Global Drug Development
September 3, 2026
Tigermed Announces 2026 Interim Results
August 28, 2026
Tigermed Announces 2025 Annual Results
March 30, 2026
Tigermed Selected as "2025 Forbes China Go-International Flagship Brands" Top 30
November 6, 2025
Tigermed Receives MSCI ESG AAA Rating
August 17, 2025
Tigermed Completes Acquisition of Japanese CRO Micron
July 29, 2025
Tigermed Reports Full Year 2024 Results
March 27, 2025
Tigermed Reports 2023 Interim Results
August 28, 2023
Hangzhou Tigermed Consulting : 2020 Tigermed Sustainability Report And Environmental, Social and Governance Report
April 30, 2021
Hangzhou Tigermed Consulting : (1) PROPOSED PARTIAL REPURCHASE AND CANCELLATION OF THE 2019 RESTRICTED A SHARES; (2) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; AND (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
March 29, 2021
Hangzhou Tigermed Consulting : (1) PROPOSED PARTIAL REPURCHASE AND CANCELLATION OF THE 2019 RESTRICTED A SHARES; (2) PROPOSED CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; (3) PROPOSED CHANGE OF THE REGISTERED ADDRESS OF THE COMPANY; AND (4) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
August 28, 2020
Hangzhou Tigermed Consulting : 2019 Sustainability Report
August 10, 2020
Hangzhou Tigermed Consulting : Tigermed Lauded by Frost & Sullivan for Its Rapid, Large-Scale Clinical Developmental Services
June 2, 2020